BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 5421555)

  • 1. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 2. Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.
    Chainuvati T; Plengvanit U; Viranuvatti V
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):434-9. PubMed ID: 602619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of alpha ornithine ketoglutarate].
    Linquette M; Fossati P; Hubschman B
    Lille Med; 1969 Apr; 14():Suppl 3:512-5. PubMed ID: 5376446
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of ornithine-ketoglutarate on provoked hyperammonaemia in patients with cirrhosis of the liver (author's transl)].
    Blahíková L; Horký J; Pechar J; Vidlaková M; Zvolánková K; Vosmík J; Marecková O
    Cesk Gastroenterol Vyz; 1978 Jun; 32(4):262-7. PubMed ID: 688420
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].
    Girard PF; Trillet M; Kopp N
    Rev Neurol (Paris); 1972 Nov; 127(5):560-3. PubMed ID: 4668744
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 8. [On therapy of hepatic coma with metabolites of the urea cycle, glutamate and alpha-ketoglutarate].
    Meuret G; Beck K; Keul J; Gruenagel HH
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1194-7. PubMed ID: 5651556
    [No Abstract]   [Full Text] [Related]  

  • 9. [The so called hepatic encephalopathy. Pathophysiology and diagnosis].
    Spatz R; Kollmannsberger A
    Munch Med Wochenschr; 1971 Sep; 113(39):1250-4. PubMed ID: 5171156
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

  • 11. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
    Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and physiopathological study of hepatic encephalopathy].
    Spatz R; Kollmannsgerger A
    Minerva Med; 1972 Feb; 63(12):721-6. PubMed ID: 5012554
    [No Abstract]   [Full Text] [Related]  

  • 13. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
    Bircher J; Haemmerli UP; Williams R
    Gastroenterology; 1970 Apr; 58(4):595-7. PubMed ID: 5438009
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution to the treatment of portal systemic encephalopathy (author's transl)].
    Blahníková L; Horký J; Pechar J; Honzák R; Vosmík J
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):486-93. PubMed ID: 737756
    [No Abstract]   [Full Text] [Related]  

  • 15. Lactulose: comments on mechanism of action and current status.
    Conn HO
    Conn Med; 1972 Oct; 36(10):582-6. PubMed ID: 5086118
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hepatic comas by ornithine alpha-ketoglutarate].
    Tête R; Paliard P; Vachon A
    Rev Lyon Med; 1966 Apr; 15(8):371-8. PubMed ID: 5942225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis and therapy of exogenous hepatic coma].
    Leonhardt H
    Fortschr Med; 1973 Jan; 91(1):35-8. PubMed ID: 4699340
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatic encephalopathy and selective amino acid solutions].
    De Martiis M; D'Ottavi R; Fontana M; Patrizi P
    Clin Ter; 1983 Jan; 104(1):53-8. PubMed ID: 6337772
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic encephalopathy: comparative study of EEG abnormalities, neuropsychic disturbances and blood ammonia.
    Demedts M; Pillen E; De Groote J; Van de Woestijne KP
    Acta Neurol Belg; 1973; 73(5):281-8. PubMed ID: 4785018
    [No Abstract]   [Full Text] [Related]  

  • 20. EEG-provocative tests in the diagnosis of hepatic encephalopathy.
    Hawkes CH; Brunt PW; Prescott RJ; Horn DB
    Electroencephalogr Clin Neurophysiol; 1973 Feb; 34(2):163-9. PubMed ID: 4119529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.